Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,065.00    -55.00 (-1.07%)
Bid:
5,055.00
Ask:
5,065.00
Spread: 10.00 (0.198%)
Market Cap: £3.68b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Form 8.3 - Renishaw PLC

12 May 2021 11:28

RNS Number : 3971Y
Baillie Gifford & Co.
12 May 2021
Ā 

FORMĀ 8.3

Ā 

PUBLICĀ OPENINGĀ POSITIONĀ DISCLOSURE/DEALINGĀ DISCLOSUREĀ BY

AĀ PERSONĀ WITHĀ INTERESTSĀ INĀ RELEVANTĀ SECURITIESĀ REPRESENTINGĀ 1%Ā OR MORE

RuleĀ 8.3Ā ofĀ theĀ TakeoverĀ CodeĀ (theĀ "Code")

Ā 

1. KEYĀ INFORMATION

Ā 

(a) Full name of discloser:

Baillie Gifford & Co

(b) Owner or controller of interests and short

positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose

relevant securities this form relates:

Use a separate form for each offeror/offeree

Renishaw Plc

(d) If an exempt fund manager connected with an

offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

11 May 2021

(f) In addition to the company in 1(c) above, is the

discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

Ā 

Ā 

2. POSITIONSĀ OFĀ THEĀ PERSONĀ MAKINGĀ THEĀ DISCLOSURE

Ā 

IfĀ thereĀ areĀ positionsĀ orĀ rightsĀ toĀ subscribeĀ toĀ discloseĀ inĀ moreĀ thanĀ oneĀ classĀ ofĀ relevant securitiesĀ ofĀ theĀ offerorĀ orĀ offereeĀ namedĀ in 1(c),Ā copyĀ tableĀ 2(a)Ā orĀ (b)Ā (as appropriate)Ā for eachĀ additionalĀ classĀ of relevantĀ security.

Ā 

(a) InterestsĀ andĀ shortĀ positionsĀ inĀ theĀ relevantĀ securitiesĀ ofĀ theĀ offerorĀ orĀ offeree toĀ whichĀ theĀ disclosureĀ relatesĀ followingĀ theĀ dealingĀ (ifĀ any)

Ā 

Class of relevant security:

20p Ordinary

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned

and/or controlled:

4,992,161

6.86

(2) Cash-settled derivatives:

(3) Stock-settled derivatives

(including options) and agreements to purchase/sell:

Ā 

TOTAL:

4,992,161

6.86

Ā 

AllĀ interestsĀ andĀ allĀ shortĀ positionsĀ shouldĀ be disclosed.

Ā 

Details Ā of Ā any Ā open Ā stock-settled Ā derivative Ā positions Ā (including Ā traded Ā options), Ā or agreementsĀ toĀ purchaseĀ orĀ sellĀ relevantĀ securities,Ā shouldĀ beĀ givenĀ onĀ aĀ Supplemental FormĀ 8Ā (OpenĀ Positions).

(b) RightsĀ toĀ subscribeĀ forĀ newĀ securitiesĀ (includingĀ directors'Ā andĀ otherĀ employee options)

Ā 

Class of relevant security in relation to

which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Ā 

Ā 

3. Ā DEALINGSĀ (IFĀ ANY)Ā BYĀ THEĀ PERSONĀ MAKINGĀ THEĀ DISCLOSURE

Ā 

WhereĀ thereĀ have beenĀ dealingsĀ in moreĀ than oneĀ classĀ of relevantĀ securitiesĀ of theĀ offerorĀ or offeree named inĀ 1(c), copyĀ table 3(a), (b), (c)Ā orĀ (d)Ā (asĀ appropriate)Ā forĀ each additionalĀ class ofĀ relevantĀ securityĀ dealtĀ in.

Ā 

TheĀ currencyĀ ofĀ allĀ pricesĀ andĀ otherĀ monetaryĀ amountsĀ shouldĀ beĀ stated.

Ā 

(a) Ā PurchasesĀ andĀ sales

Ā 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

20p Ordinary

Purchase

2,511

56.265

Ā 

(b) Cash-settledĀ derivativeĀ transactions

Ā 

Class of

relevant security

Product

description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of

reference securities

Price per

unit

Ā 

(c) Stock-settledĀ derivativeĀ transactionsĀ (includingĀ options)

Ā 

(i) Writing,Ā selling,Ā purchasingĀ orĀ varying

Ā 

Class

of relevant security

Product

description e.g. call option

Writing,

purchasing, selling, varying etc.

Number

of securities to which option relates

Exercise

price per unit

Type

e.g. American, European etc.

Expiry

date

Option

money paid/ received per unit

Ā 

(ii) Exercise

Ā 

Class of

relevant security

Product

description

e.g. call option

Exercising/

exercised against

Number of

securities

Exercise price

per unit

(d) OtherĀ dealingsĀ (includingĀ subscribingĀ forĀ newĀ securities)

Ā 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Ā 

Ā 

4. OTHERĀ INFORMATION

Ā 

(a) IndemnityĀ andĀ otherĀ dealingĀ arrangements

Ā 

DetailsĀ ofĀ anyĀ indemnityĀ orĀ optionĀ arrangement,Ā orĀ anyĀ agreementĀ orĀ understanding, formalĀ orĀ informal,Ā relatingĀ toĀ relevantĀ securitiesĀ whichĀ mayĀ beĀ anĀ inducementĀ toĀ deal orĀ refrainĀ fromĀ dealingĀ enteredĀ intoĀ byĀ theĀ personĀ makingĀ theĀ disclosureĀ andĀ anyĀ party toĀ theĀ offerĀ orĀ anyĀ personĀ actingĀ inĀ concertĀ withĀ aĀ partyĀ toĀ theĀ offer:

IrrevocableĀ commitmentsĀ andĀ lettersĀ of intentĀ shouldĀ notĀ be included.Ā IfĀ thereĀ areĀ noĀ such agreements,Ā arrangementsĀ orĀ understandings,Ā stateĀ "none"

Ā 

None

Ā 

Ā 

Ā 

(b) Agreements,Ā arrangementsĀ orĀ understandingsĀ relatingĀ toĀ optionsĀ orĀ derivatives

Ā 

DetailsĀ ofĀ anyĀ agreement,Ā arrangementĀ orĀ understanding,Ā formalĀ orĀ informal,Ā between theĀ personĀ makingĀ theĀ disclosureĀ andĀ anyĀ otherĀ personĀ relatingĀ to:

(i)Ā theĀ votingĀ rightsĀ ofĀ anyĀ relevantĀ securitiesĀ underĀ anyĀ option;Ā or

(ii)Ā theĀ votingĀ rightsĀ orĀ futureĀ acquisitionĀ orĀ disposalĀ ofĀ anyĀ relevantĀ securitiesĀ toĀ which anyĀ derivativeĀ isĀ referenced:

IfĀ thereĀ areĀ noĀ suchĀ agreements,Ā arrangementsĀ orĀ understandings,Ā stateĀ "none"

Ā 

Ā 

None

Ā 

Ā 

(c) Attachments

Ā 

IsĀ aĀ SupplementalĀ FormĀ 8 (OpenĀ Positions)Ā attached? NO

Ā 

Ā 

Ā 

Date of disclosure:

12.05.2021

Contact name:

Alan Gilliland-Patterson

Telephone number:

0131 275 3779

Ā 

PublicĀ disclosuresĀ underĀ RuleĀ 8Ā ofĀ theĀ CodeĀ mustĀ beĀ madeĀ toĀ aĀ RegulatoryĀ Information

Service.

Ā 

TheĀ Panel'sĀ MarketĀ SurveillanceĀ UnitĀ isĀ availableĀ forĀ consultationĀ inĀ relationĀ toĀ theĀ Code's disclosureĀ requirementsĀ on +44Ā (0)20Ā 7638Ā 0129.

Ā 

TheĀ CodeĀ canĀ be viewedĀ onĀ the Panel'sĀ websiteĀ atĀ Ā www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
RETSFMFSEEFSEEI
Date   Source Headline
16th Jun 20267:00 amRNSCapital Markets Day
6th May 20267:00 amRNSTrading Statement
20th Apr 20267:00 amRNSTrading Statement
8th Apr 20267:00 amRNSBoard Changes
11th Feb 20267:00 amRNSHalf-year Financial Report
29th Jan 202612:00 pmRNSNotice of Half-year Results
28th Nov 202511:00 amRNSHolding(s) in Company
28th Nov 202511:00 amRNSHolding(s) in Company
27th Nov 20256:29 pmRNSHolding(s) in Company
27th Nov 20255:00 pmRNSDirector/PDMR Shareholding
26th Nov 20251:32 pmRNSResult of AGM
26th Nov 20258:30 amRNSShareholdings update
29th Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 20257:00 amRNSTrading Statement
21st Oct 20253:02 pmRNSVoting Arrangement
21st Oct 20253:00 pmRNSHolding(s) in Company
21st Oct 20253:00 pmRNSHolding(s) in Company
3rd Oct 20257:00 amRNSAnnual Financial Report
24th Sep 20257:00 amRNSDirector/PDMR Shareholding
23rd Sep 20257:00 amRNSNew reporting segments for FY2026
18th Sep 20257:00 amRNSFinal Results
21st Aug 20257:00 amRNSBoard Change and Trading Update
13th Aug 20257:00 amRNSDirectorate Change
17th Jun 20257:00 amRNSCapital Markets Day
8th May 20257:00 amRNSTrading Statement
14th Apr 20259:49 amRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSHalf-year Report
9th Dec 20242:02 pmRNSDeath of Sir David McMurtry
27th Nov 20242:44 pmRNSResult of AGM
29th Oct 20241:28 pmRNSDirector/PDMR Shareholding
24th Oct 20247:00 amRNSTrading Statement
27th Sep 20247:15 amRNSAnnual Financial Report
12th Sep 20247:00 amRNSFinal Results
29th Aug 20242:00 pmRNSNotice of Results
1st Jul 20247:00 amRNSDirectorate Change
13th Jun 20247:00 amRNSDirectorate Change
16th May 20242:25 pmRNSAGM Voting Results Update Statement
8th May 20247:00 amRNSTrading Statement
2nd Apr 20245:19 pmRNSStatement regarding Renishaw plc
6th Feb 20247:00 amRNSHalf-year Report
30th Jan 202410:30 amRNSChange of Adviser
23rd Jan 20249:00 amRNSNotice of Half-year Results
29th Nov 20232:47 pmRNSResult of AGM
26th Oct 20237:00 amRNSTrading Statement
13th Oct 20237:00 amRNSNotice of AGM
3rd Oct 20237:00 amRNSAnnual Financial Report
19th Sep 20237:00 amRNSFinal Results
13th Sep 20237:00 amRNSRevised date for publication of results
21st Aug 20233:00 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.